callfree now
US Toll Free:
Regular US:
UK Phone:
Perform search

Welcome to Canada Pharmacy

We are glad to offer you the most popular Generic medications that successfully substitute costly brand name drugs nowadays. These high quality generics will meet the exacting standards you expect from a Canada Pharmacy.

Trial Packs

Trial Packs
Viagra + Cialis + Levitra

Our benefits:

World wide shipping Discreet packaging Privacy guarantee Widest product selection 24/7 customer support

Live Support

Live Support

Your cart

$0.00 (0 items)   Checkout

Categories list

What are generics? Medications by A/Z Pharmaceutical news and reviews

Articles


Choose your language:
English / GBPFrançais  / EURDeutch / EUREspañol / EURItaliano / EURPortuguês / EUREnglish / EUREspañol / USDPortuguês / USDFrançais  / USD


We accept:


Our billing is certified by:
Secure shopping certificates

Hydrea
$ 3.11
Generic Hydrea
(Hydroxyurea 500mg)
Kytril
$ 2.00
Generic Kytril
(Granisetron 1mg)
Leukeran
$ 0.00
Generic Leukeran
(Chlorambucil 2mg)
Nolvadex
$ 0.87
Generic Nolvadex
(Tamoxifen 10/20mg)
Rheumatrex
$ 0.75
Generic Rheumatrex
(Methotrexate 2.5mg)
Vepesid
$ 10.00
Generic Vepesid
(Etoposide 50mg)


Cancer (medical term: malignant neoplasm) is a class of diseases in which a group of cells display uncontrolled growth (division beyond the normal limits), invasion (intrusion on and destruction of adjacent tissues), and sometimes metastasis (spread to other locations in the body via lymph or blood). These three malignant properties of cancers differentiate them from benign tumors, which are self-limited, and do not invade or metastasize. Most cancers form a tumor but some, like leukemia, do not. The branch of medicine concerned with the study, diagnosis, treatment, and prevention of cancer is oncology.

Cancer may affect people at all ages, even fetuses, but the risk for most varieties increases with age. Cancer causes about 13% of all human deaths. According to the American Cancer Society, 7.6 million people died from cancer in the world during 2007. Cancers can affect all animals.

Nearly all cancers are caused by abnormalities in the genetic material of the transformed cells. These abnormalities may be due to the effects of carcinogens, such as tobacco smoke, radiation, chemicals, or infectious agents. Other cancer-promoting genetic abnormalities may be randomly acquired through errors in DNA replication, or are inherited, and thus present in all cells from birth. The heritability of cancers is usually affected by complex interactions between carcinogens and the host's genome. New aspects of the genetics of cancer pathogenesis, such as DNA methylation, and microRNAs are increasingly recognized as important.

Genetic abnormalities found in cancer typically affect two general classes of genes. Cancer-promoting oncogenes are typically activated in cancer cells, giving those cells new properties, such as hyperactive growth and division, protection against programmed cell death, loss of respect for normal tissue boundaries, and the ability to become established in diverse tissue environments. Tumor suppressor genes are then inactivated in cancer cells, resulting in the loss of normal functions in those cells, such as accurate DNA replication, control over the cell cycle, orientation and adhesion within tissues, and interaction with protective cells of the immune system.

Diagnosis usually requires the histologic examination of a tissue biopsy specimen by a pathologist, although the initial indication of malignancy can be symptoms or radiographic imaging abnormalities. Most cancers can be treated and some cured, depending on the specific type, location, and stage. Once diagnosed, cancer is usually treated with a combination of surgery, chemotherapy and radiotherapy. As research develops, treatments are becoming more specific for different varieties of cancer. There has been significant progress in the development of targeted therapy drugs that act specifically on detectable molecular abnormalities in certain tumors, and which minimize damage to normal cells. The prognosis of cancer patients is most influenced by the type of cancer, as well as the stage, or extent of the disease. In addition, histologic grading and the presence of specific molecular markers can also be useful in establishing prognosis, as well as in determining individual treatments.

Signs and symptoms

Roughly, cancer symptoms can be divided into three groups:

  • Local symptoms: unusual lumps or swelling (tumor), hemorrhage (bleeding), pain and/or ulceration. Compression of surrounding tissues may cause symptoms such as jaundice (yellowing the eyes and skin).
  • Symptoms of metastasis (spreading): enlarged lymph nodes, cough and hemoptysis, hepatomegaly (enlarged liver), bone pain, fracture of affected bones and neurological symptoms. Although advanced cancer may cause pain, it is often not the first symptom.
  • Systemic symptoms: weight loss, poor appetite, fatigue and cachexia (wasting), excessive sweating (night sweats), anemia and specific paraneoplastic phenomena, i.e. specific conditions that are due to an active cancer, such as thrombosis or hormonal changes.

Every symptom in the above list can be caused by a variety of conditions (a list of which is referred to as the differential diagnosis). Cancer may be a common or uncommon cause of each item.

Leukeran
$ 0.00
Generic Leukeran
(Chlorambucil 2mg)
Nolvadex
$ 0.87
Generic Nolvadex
(Tamoxifen 10/20mg)
Rheumatrex
$ 0.75
Generic Rheumatrex
(Methotrexate 2.5mg)
Vepesid
$ 10.00
Generic Vepesid
(Etoposide 50mg)
Casodex
$ 4.65
Generic Casodex
(Bicalutamide 50mg)
Cytoxan
$ 0.83
Generic Cytoxan
(Cyclophosphamide 50mg)



  • Breast cancer kills older women more often - Chicago Tribune

    ABC NewsBreast cancer kills older women more oftenChicago TribuneNEW YORK (Reuters Health) - Breast cancer is often considered more deadly among younger women, but a new study shows older women are actually more likely to die of the disease.

  • After Outcry, a Senior Official Resigns at Komen - New York Times

    Los Angeles TimesAfter Outcry, a Senior Official Resigns at KomenNew York TimesBy restoring Planned Parenthood's eligibility for grants on Friday, the Komen foundation, the nation's most influential breast cancer advocacy organization, sought to quiet the criticism that engulfed it last week after its decision to cut .

  • Cancer patient raises environmental concerns over chemo drugs - KING5.com

    Cancer patient raises environmental concerns over chemo drugsKING5.

  • FDA questions Amgen drug for prostate cancer - USA TODAY

    USA TODAYFDA questions Amgen drug for prostate cancerUSA TODAYWASHINGTON – Scientists for the Food and Drug Administration say that an Amgen drug slowed the spread of cancer to the bone in men with hard-to-treat prostate cancer, though the drug did not extend life and carried significant side effects.

  • Ovarian Cancer Screening Common Despite No Proof - MedPage Today

    Zee NewsOvarian Cancer Screening Common Despite No ProofMedPage TodayNote that primary care physicians reported using both transvaginal ultrasound and CA-125 screening for ovarian cancer even in low- or moderate-risk patients, despite absence of data that screening is effective.


prescriptionmedsdirectory.com
Canadian Pharmacy

Social bookmarks: